Nonstandard personalized medicine strategies for cancer may lead to improved patient outcomes

Personalized Medicine
Robert A Beckman, Chen-Hsiang Yeang

Abstract

Cancer is an evolutionary process that is driven by mutation and selection. Tumors are genetically unstable, and research has shown that this is the most efficient way for cancers to evolve. Genetic instability leads to genetic heterogeneity and dynamic change within a single individual's tumor, in turn leading to therapeutic resistance. Cancer treatment has also evolved from an empirical science of killing dividing cells to the current era of 'personalized medicine', exquisitely targeting the molecular features of individual cancers. However, current personalized medicine regards a single individual's cancer as largely uniform and static. Moreover, from a strategic perspective, current personalized medicine thinks primarily of the immediate therapy selection. Ongoing research suggests that new, nonstandard personalized treatment strategies that plan further ahead and consider intratumoral heterogeneity and the evolving nature of cancer (due to genetic instability) may lead to the next level of therapeutic benefit beyond current personalized medicine.

References

Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Rachel B CervantesPeter J Stambrook
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Jul 27, 2005·Seminars in Cancer Biology·Robert A Beckman, Lawrence A Loeb
Sep 7, 2005·Genetics·Robert A Beckman, Lawrence A Loeb
May 27, 2006·Science·William S Dalton, Stephen H Friend
Sep 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Robert A Beckman, Lawrence A Loeb
May 17, 2008·Cancer Research·Lawrence A LoebRobert A Beckman
Jul 4, 2008·The New England Journal of Medicine·Shyamala MaheswaranDaniel A Haber
Jul 8, 2008·Neurobiology of Learning and Memory·Stephen Marsland
Nov 29, 2008·Science·Charles G MullighanJames R Downing
May 22, 2009·Cancer Research·Natalia L Komarova, Dominik Wodarz
Jun 3, 2009·Cancer Research·Robert A GatenbyB Roy Frieden
Sep 16, 2009·Cancer Research·Robert A GatenbyThomas Vincent
Dec 18, 2009·Nature·Erin D PleasanceMichael R Stratton
Dec 18, 2009·Nature·Erin D PleasancePeter J Campbell
Feb 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuhang WangMeina Wu
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Oct 12, 2010·Seminars in Cancer Biology·Robert A Beckman
Oct 29, 2010·Nature·Shinichi YachidaChristine A Iacobuzio-Donahue
Dec 28, 2010·Nature Chemical Biology·Hai JiangMichael T Hemann
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jun 3, 2011·Genome Medicine·Nicholas Navin, James Hicks
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Oct 1, 2011·Nature Reviews. Drug Discovery·Robert A BeckmanCong Chen
Oct 18, 2011·Proceedings of the National Academy of Sciences of the United States of America·Laura M HeiserPaul T Spellman
Jan 13, 2012·Nature·Jinghui ZhangMichael A Dyer
Jan 27, 2012·Science Translational Medicine·Ryohei KatayamaJeffrey A Engelman
Feb 11, 2012·Nature Reviews. Drug Discovery·Gary J Kelloff, Caroline C Sigman
Feb 24, 2012·The New England Journal of Medicine·Jeffrey A SosmanAntoni Ribas
Mar 3, 2012·Nature·David B Solit, Pasi A Jänne
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
Apr 28, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tracy A Denison, You Han Bae

❮ Previous
Next ❯

Citations

Jun 23, 2019·Journal of Medical Ethics·Rosalind J McDougall
Sep 30, 2020·Cancer Control : Journal of the Moffitt Cancer Center·Robert A BeckmanFrederick R Adler
Oct 25, 2016·Biology Direct·Chen-Hsiang Yeang, Robert A Beckman

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
single-cell sequencing

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Robert A BeckmanChen-Hsiang Yeang
Surgical Neurology International
Chibawanye I Ene, Eric C Holland
American Journal of Respiratory and Critical Care Medicine
Jacob I Sznajder, Aaron Ciechanover
© 2022 Meta ULC. All rights reserved